Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (9): 886-891    DOI: 10.19485/j.cnki.issn2096-5087.2025.09.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较
陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文
上海市青浦区疾病预防控制中心(上海市青浦区卫生健康监督所),上海 201799
Comparison of the effect of obesity indicators in predicting cardiovascular and cerebrovascular diseases among patients with type 2 diabetes mellitus
LU Jie, ZHANG Ke, WU Ya, WANG Yue, ZHANG Yue, LU Ye, WU Zhouli, REN Zhihua, HUANG Yiwen
Qingpu District Center for Disease Control and Prevention (Qingpu District Institute of Public Health Supervision), Shanghai 201799, China
全文: PDF(822 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨不同肥胖指标预测2型糖尿病(T2DM)患者心脑血管疾病(CVD)风险的效果,为T2DM患者CVD风险早期识别提供依据。方法 于2025年1月选择上海市青浦区社区管理的T2DM患者为调查对象,通过上海市慢性病管理信息系统收集性别、年龄和血糖控制情况等基本资料,通过居民电子健康档案和上海市疾病控制信息平台收集CVD病史等资料;采用体质指数(BMI)、腰围(WC)、BMI联合WC、腰高比(WHtR)和三酰甘油(TG)联合WC指标评估肥胖。采用多因素logistic回归模型分析肥胖与CVD的关联,采用受试者操作特征曲线下面积(AUC)评价各肥胖指标预测CVD的效果。结果 纳入4 367例T2DM患者,其中男性2 121例,占48.57%;女性2 246例,占51.43%。年龄为(68.71±8.05)岁。CVD患病率为44.49%。多因素logistic回归分析结果显示,校正年龄、文化程度、高血压史、T2DM病程、服用降糖药物、肾功能和血糖控制情况后,与BMI正常T2DM患者相比,肥胖T2DM患者CVD风险增加389.4%;与WC正常T2DM患者相比,中心型肥胖T2DM患者CVD风险增加100.4%;与BMI联合WC正常T2DM患者相比,单纯全身型肥胖、复合型肥胖T2DM患者CVD风险分别增加161.0%和241.1%;与WHtR正常T2DM患者相比,中心型肥胖T2DM患者CVD风险增加100.4%;与TG联合WC正常T2DM患者相比,正常TG-高WC、高TG-WC表型T2DM患者CVD风险分别增加83.1%和68.8%(均P<0.05)。BMI的AUC值最大,为0.714,灵敏度和特异度分别为0.675和0.642;其次为BMI联合WC,AUC值为0.707,灵敏度和特异度分别为0.635和0.679。结论 BMI、WC、BMI联合WC、WHtR和TG联合WC定义的肥胖均增加T2DM患者CVD风险,BMI、BMI联合WC预测T2DM患者CVD风险的效果较好,可作为CVD风险筛查的主要肥胖指标。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
陆杰
张柯
吴雅
王玥
张玥
陆叶
吴周理
任志华
黄艺文
关键词 2型糖尿病心脑血管疾病肥胖指标    
AbstractObjective To explore the effect of different obesity indicators in predicting cardiovascular and cerebrovascular diseases (CVD) risk among patients with type 2 diabetes mellitus (T2DM), so as to provide the evidence for the early identification of CVD risk among T2DM patients. Methods The patients with T2DM under community management in Qingpu District, Shanghai Municipality were selected as the study subjects in January 2025. Basic information such as gender, age, and blood glucose control status were collected through the Shanghai Chronic Disease Information Management System, while history of CVD were obtained from residents' electronic health records and the Shanghai Disease Control Information Platform. Obesity was assessed using body mass index (BMI), waist circumference (WC), BMI combined with WC, waist-to-height ratio (WHtR), and triglyceride (TG) combined with WC indicators. The association between obesity and CVD was analyzed using multivariable logistic regression models. The predictive effect of each obesity indicators for CVD was evaluated using the area under the receiver operating characteristic curve (AUC). Results A total of 4 367 patients with T2DM were included, including 2 121 males (48.57%) and 2 246 females (51.43%). The average age was (68.71±8.05) years. The prevalence of CVD was 44.49%. Multivariable logistic regression analysis showed that after adjusting for age, education level, history of hypertension, duration of T2DM, use of glucose-lowering medications, renal function, and blood glucose control status, obese T2DM patients had a 389.4% increased risk of CVD compared to those with normal BMI; centrally obese T2DM patients had a 100.4% increased risk compared to those with normal WC; T2DM patients with isolated general obesity and compound obesity had 161.0% and 241.1% increased risks of CVD, respectively, compared to those with normal BMI and WC; centrally obese T2DM patients had a 100.4% increased risk compared to those with normal WHtR; T2DM patients with normal TG-high WC and high TG-high WC phenotypes had 83.1% and 68.8% increased risks of CVD, respectively, compared to those with normal TG and normal WC (all P<0.05). BMI had the highest AUC, at 0.714, with sensitivity and specificity of 0.675 and 0.642, respectively. This was followed by BMI combined with WC, which had an AUC of 0.707, with sensitivity and specificity of 0.635 and 0.679, respectively. Conclusions Obesity defined by BMI, WC, BMI combined with WC, WHtR, and TG combined with WC increases the risk of CVD among patients with T2DM. BMI and BMI combined with WC have better predictive effect in predicting CVD risk among patients with T2DM, and can be used as the primary obesity indicators for CVD risk screening.
Key wordstype 2 diabetes mellitus    cardiovascular and cerebrovascular diseases    obesity indicator
收稿日期: 2025-05-15      修回日期: 2025-08-12      出版日期: 2025-09-10
中图分类号:  R587.1  
基金资助:青浦区卫生健康系统第五轮人才培养项目(YY2023-63); 青浦区卫生健康委员会科研项目(QWJ2024-51)
作者简介: 陆杰,硕士,主管医师,主要从事慢性病防治工作
通信作者: 黄艺文,E-mail:1563703818@qq.com   
引用本文:   
陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
LU Jie, ZHANG Ke, WU Ya, WANG Yue, ZHANG Yue, LU Ye, WU Zhouli, REN Zhihua, HUANG Yiwen. Comparison of the effect of obesity indicators in predicting cardiovascular and cerebrovascular diseases among patients with type 2 diabetes mellitus. Preventive Medicine, 2025, 37(9): 886-891.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.09.005      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I9/886
[1] 中国心血管病风险评估和管理指南编写联合委员会.中国心血管病风险评估和管理指南[J].中国循环杂志,2019,34(1):4-28.
The Joint Task Force for Guideline on the Assessment,Management of Cardiovascular Risk in China.Guideline on the assessment and management of cardiovascular risk in China[J].Chin Circ J,2019,34(1):4-28.(in Chinese)
[2] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2022概要[J].中国循环杂志,2023,38(6):583-612.
The Writing Committee of the Report on Cardiovascular Health and Diseases in China.Summary of Chinese cardiovascular health and diseases report 2022[J].Chin Circ J,2023,38(6):583-612.(in Chinese)
[3] 《中国脑卒中防治报告2021》编写组.《中国脑卒中防治报告2021》概要[J].中国脑血管病杂志,2023,20(11):783-793.
Report on Stroke Prevention Treatment in China Writing Group.Brief report on Stroke Prevention and Treatment in China,2021 [J].Chin J Cerebrovasc Dis,2023,20(11):783-793.(in Chinese)
[4] 黄文,汤佳良,陈康康,等.绍兴市心血管疾病高危人群危险因素聚集分析[J].预防医学,2023,35(4):298-302,330.
HUANG W,TANG J L,CHEN K K,et al.Clustering of risk factors among residents at high risk of cardiovascular diseases in Shaoxing City[J].China Prev Med J,2023,35(4):298-302,330.(in Chinese)
[5] 贾铭,彭菊意,刘星宇,等.心血管代谢性共病危险因素的Meta分析[J].预防医学,2023,35(9):790-795.
JIA M,PENG J Y,LIU X Y,et al.Risk factors for cardiometabolic multimorbidity:a meta-analysis[J].China Prev Med J,2023,35(9):790-795.(in Chinese)
[6] 汪煜. 超重、肥胖和2型糖尿病与心脑血管疾病的关系——基于瑞典全国双生子人群的研究[D].天津:天津医科大学,2019.
WANG Y.Association of overweight,obesity and type 2 diabetes with the risk of cardiocerebrovascular diseases:a nationwide Swedish twin study[D].Tianjin:Tianjin Medical University,2019.(in Chinese)
[7] SHARMA A,LAVIE C J,BORER J S,et al.Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure[J].Am J Cardiol,2015,115(10):1428-1434.
[8] 中国血脂管理指南修订联合专家委员会.中国血脂管理指南(基层版 2024 年)[J].中国全科医学,2024,27(20):2429-2436.
Joint Expert Committee on Revision of Chinese Blood Lipid Management Guidelines.Chinese guidelines for dyslipidemia management(primary care edition 2024)[J].Chin Gen Pract,2024,27(20):2429-2436.(in Chinese)
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
Chinese Diabetes Society of the Chinese Medical Association.Chinese clinical guidelines for type 2 diabetes prevention and treatment(2020 edition)[J].Chin J Diabetes Mellitus,2021,13(4):315-409.(in Chinese)
[10] INKER L A,ENEANYA N D,CORESH J,et al.New creatinine-and cystatin C-based equations to estimate GFR without race[J].N Engl J Med,2021,385(19):1737-1749.
[11] 中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004,26(1):1-4.
Chinese Working Group on Obesity.Guidelines for prevention and control of overweight and obesity in Chinese adults (excerpt)[J].Acta Nutr Sin,2004,26(1):1-4.(in Chinese)
[12] BROWNING L M,HSIEH S D,ASHWELL M.A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes:0.5 could be a suitable global boundary value[J].Nutr Res Rev,2010,23(2):247-269.
[13] 刘丝雨. 吉林省成人高甘油三酯-腰围表型与心血管疾病关系研究[D].长春:吉林大学,2020.
LIU S Y.Association between hypertriglyceridemic-waist phenotype and cardiovascular diseases in Jilin adults[D].Changchun:Jilin University,2020.(in Chinese)
[14] HONG T P,YAN Z X,LI L,et al.The prevalence of cardiovascular disease in adults with type 2 diabetes in China:results from the cross-sectional CAPTURE study[J].Diabetes Ther,2022,13(5):969-981.
[15] 王雨涵. 中老年2型糖尿病患者身体成分与心血管疾病的相关性研究[D].长春:吉林大学,2022.
WANG Y H.Correlation between body composition and cardiovascular diseases in middle-aged and elderly patients with type 2 diabetes[D].Changchun:Jilin University,2022.(in Chinese)
[16] 尹春宇,李亚鹏,赵笑颜,等.评估肥胖的四种指标与缺血性心脑血管病的关系[J].中华老年心脑血管病杂志,2020,22(5):487-492.
YIN C Y,LI Y P,ZHAO X Y,et al.Evaluation of the relationship between 4 indexes of obesity and ischemic cardiocerebrovascular disease[J].Chin J Geriatr Heart Brain Vessel Dis,2020,22(5):487-492.(in Chinese)
[17] 何佳,齐浩月,李毓,等.新疆哈萨克族农村居民不同肥胖程度和类型与心血管病发病关系[J].中国公共卫生,2022,38(3):297-301.
HE J,QI H Y,LI Y,et al.Associations of different degrees and types of obesity with cardiovascular disease incidence among rural Kazakh residents in Xinjiang Uygur Autonomous Region[J].Chin J Public Health,2022,38(3):297-301.(in Chinese)
[18] 马占莹,王洁蕊,宋海澄,等.正常体重中心性肥胖对新发心血管疾病和全因死亡的影响[J].中国循环杂志,2024,39(11):1110-1116.
MA Z Y,WANG J R,SONG H C,et al.Association between normal-weight central obesity with new-onset cardiovascular disease and all-cause mortality[J].Chin Circ J,2024,39(11):1110-1116.(in Chinese)
[19] LONARDO A,NASCIMBENI F,BALLESTRI S,et al.Sex differences in nonalcoholic fatty liver disease:state of the art and identification of research gaps[J].Hepatology,2019,70(4):1457-1469.
[1] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[2] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[3] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[4] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[5] 陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[6] 王英杰 综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[7] 孙霞, 但玲英, 郑鹏, 陈薪伊. 2型糖尿病患者脂肪因子与糖尿病视网膜病变的关联研究[J]. 预防医学, 2025, 37(3): 248-252.
[8] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[9] 王英杰, 孙高峰, 赵娥, 田原. 2017—2021年乌鲁木齐市2型糖尿病患者管理指标分析[J]. 预防医学, 2025, 37(1): 92-95.
[10] 崔彦泽, 张玲, 蒋璐, 李慧敏, 王硕. 衰弱与2型糖尿病的孟德尔随机化研究[J]. 预防医学, 2024, 36(9): 786-789.
[11] 郑帅印, 李丽丹, 陈佩弟, 谢尔瓦妮古丽·阿卜力米提, 李砥. 2型糖尿病合并非酒精性脂肪肝的预测模型研究[J]. 预防医学, 2024, 36(9): 741-745,749.
[12] 李欢, 张敬红, 余丹, 金文舒, 倪少梅, 吴天凤. 老年2型糖尿病患者血清维生素D与甲状腺功能指标的关联分析[J]. 预防医学, 2024, 36(8): 702-705.
[13] 王慧, 高霞, 朱晓云, 马芳军. 社区2型糖尿病患者血糖控制达标的影响因素分析[J]. 预防医学, 2024, 36(5): 423-427.
[14] 吴丹红, 王伟霞, 王良友, 乔冬菊, 黄依璐, 张嫣. 台州市4类慢性病死亡及早死概率分析[J]. 预防医学, 2024, 36(5): 428-431,436.
[15] 周梦姣, 李美琳, 孔利萍. 老年2型糖尿病患者社会疏离感的影响因素研究[J]. 预防医学, 2024, 36(4): 292-295.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed